Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-Based Approaches to Cutaneous T-Cell Lymphoma
Irene Scarfò, Matthew J. Frigault, Marcela V. Maus
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 21

Showing 21 citing articles:

Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020
Małgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 10, pp. 733-745
Open Access | Times Cited: 42
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy
Jingjing Ren, Xiaofeng Liao, Julia M. Lewis, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL NOS, ALCL, TFHs)
Alison J. Moskowitz, Robert Stuver, Steven M. Horwitz
Blood (2024) Vol. 144, Iss. 18, pp. 1887-1897
Closed Access | Times Cited: 5
T cells in the skin: Lymphoma and inflammatory skin disease
Ben Roediger, Christoph Schlapbach
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 4, pp. 1172-1184
Open Access | Times Cited: 18
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Synergistic combination of oncolytic virotherapy with CAR T-cell therapy
Adam Ajina, John Maher
Progress in molecular biology and translational science (2019), pp. 217-292
Closed Access | Times Cited: 17
Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas
Maëlle Dumont, Régis Peffault de Latour, C. Ram‐Wolff, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2856-2856
Open Access | Times Cited: 15
Emerging drugs for the treatment of cutaneous T-cell lymphoma
Melissa Cheng, Jasmine Zain, Steven T. Rosen, et al.
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 1, pp. 45-54
Open Access | Times Cited: 9
Are we there yet? cellular therapies for cutaneous T cell lymphoma
Pınar Ataca Atilla, Erden Atilla
Current Research in Translational Medicine (2023) Vol. 71, Iss. 2, pp. 103390-103390
Closed Access | Times Cited: 4
Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine
Matthew W. McCarthy
Expert Review of Anti-infective Therapy (2020) Vol. 18, Iss. 8, pp. 799-805
Open Access | Times Cited: 11
From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future Perspectives
Elisaveta Voynova, Damián Kovalovsky
Cells (2021) Vol. 10, Iss. 11, pp. 2845-2845
Open Access | Times Cited: 8
New nonchemotherapy treatment options for cutaneous T-cell lymphomas
Suzanne Xu, Francine M. Foss
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 9, pp. 1017-1028
Closed Access | Times Cited: 4
A Yale Dermatology Perspective on Cutaneous T-Cell Lymphoma: Historical Reflection to Emerging Therapies
Madisen A. Swallow, Richard L. Edelson, Michael Girardi
Clinics in Dermatology (2024)
Closed Access
Modulating the immunosuppressive tumor microenvironment: Multi-synergistic cancer therapeutic approach with oncolytic viruses
Michael Tosin Bayode, Olamide Joshua Babatunde, Prosper Obed Chukwuemeka, et al.
World Journal of Advanced Research and Reviews (2024) Vol. 21, Iss. 1, pp. 543-559
Open Access
Targeting TAG-72 in cutaneous T cell lymphoma
Vera Evtimov, Maree V. Hammett, Aleta Pupovac, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36298-e36298
Closed Access
Treatment options for T-cell lymphomas: a single-center study
Elena E. Lepik, Andrey V. Kozlov, Evgenia Borzenkova, et al.
Cellular Therapy and Transplantation (2020) Vol. 9, Iss. 1, pp. 28-37
Open Access | Times Cited: 2
New insight into the pathogenesis of Mycosis fungoides and Sérazy syndrome
Ágnes Tósaki, Éva Remenyik
Bőrgyógyászati és Venerológiai Szemle (2020) Vol. 96, Iss. 5, pp. 236-246
Open Access | Times Cited: 1
Cutaneous T Cell Lymphoma: Ready to Enter the World of Allogeneic Transplant?
Shahab Babakoohi
Biology of Blood and Marrow Transplantation (2019) Vol. 26, Iss. 1, pp. e5-e6
Open Access
The peripheral T-cell lymphoma: can we pivot from the chemotherapy-predicated paradigm?
Helen Ma, Enrica Marchi
Journal of Cancer Metastasis and Treatment (2022) Vol. 8, Iss. 5, pp. 25-25
Open Access
Evolving strategies in T-cell lymphoma
Anca Prica
Canadian Hematology Today (2022)
Open Access
Traitement des lymphomes T cutanés par allogreffe de cellules souches hématopoïétiques
Adèle de Masson, Régis Peffault de Latour, C. Ram‐Wolff, et al.
Annales de Dermatologie et de Vénéréologie - FMC (2021) Vol. 1, Iss. 3, pp. 187-192
Closed Access
Page 1

Scroll to top